TrialScientific reports2024

The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A.

Asal Neshatbini Tehrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.